Research ArticleArticle
Risk of Cancer in 767 Patients with Giant Cell Arteritis in Western Norway: A Retrospective Cohort with Matched Controls
Lene Kristin Brekke, Bjørg-Tilde Svanes Fevang, Andreas P. Diamantopoulos, Jörg Assmus, Elisabet Esperø and Clara Gram Gjesdal
The Journal of Rheumatology July 2019, jrheum.190147; DOI: https://doi.org/10.3899/jrheum.190147
Lene Kristin Brekke
From the Hospital for Rheumatic Diseases, Haugesund; Department of Clinical Science, University of Bergen, Bergen; Bergen Group of Epidemiology and Biomarkers in Rheumatic Disease (BEaBIRD), Department of Rheumatology, and Centre for Clinical Research, Haukeland University Hospital, Bergen; Martina Hansens Hospital, Bærum, Norway. This work was supported by unrestricted research grants from the Norwegian Association of Heart and Lung Patients; The Norwegian Rheumatism Association; Marit Hansens Memorial Fund; Merck Sharp & Dohme; Odd Fellow Medical Research Fund; and The Raagholt Foundation. L.K. Brekke, MD, Hospital for Rheumatic Diseases, and Department of Clinical Science, University of Bergen; B.T. Fevang, MD, PhD, Department of Clinical Science, University of Bergen, and BEaBIRD, Department of Rheumatology, Haukeland University Hospital; A.P. Diamantopoulos, MD, PhD, MPH, Martina Hansens Hospital; J. Assmus, PhD, Centre for Clinical Research, Haukeland University Hospital; E. Esperø, MD, Hospital for Rheumatic Diseases; C. Gram Gjesdal, MD, PhD, Department of Clinical Science, University of Bergen, and BEaBIRD, Department of Rheumatology, Haukeland University Hospital. Address correspondence to Dr. L.K. Brekke, HSR AS, PB 2175, 5504 Haugesund, Norway. E-mail: lene.kristin.brekke@hsr.as. Accepted for publication June 25, 2019.
Bjørg-Tilde Svanes Fevang
From the Hospital for Rheumatic Diseases, Haugesund; Department of Clinical Science, University of Bergen, Bergen; Bergen Group of Epidemiology and Biomarkers in Rheumatic Disease (BEaBIRD), Department of Rheumatology, and Centre for Clinical Research, Haukeland University Hospital, Bergen; Martina Hansens Hospital, Bærum, Norway. This work was supported by unrestricted research grants from the Norwegian Association of Heart and Lung Patients; The Norwegian Rheumatism Association; Marit Hansens Memorial Fund; Merck Sharp & Dohme; Odd Fellow Medical Research Fund; and The Raagholt Foundation. L.K. Brekke, MD, Hospital for Rheumatic Diseases, and Department of Clinical Science, University of Bergen; B.T. Fevang, MD, PhD, Department of Clinical Science, University of Bergen, and BEaBIRD, Department of Rheumatology, Haukeland University Hospital; A.P. Diamantopoulos, MD, PhD, MPH, Martina Hansens Hospital; J. Assmus, PhD, Centre for Clinical Research, Haukeland University Hospital; E. Esperø, MD, Hospital for Rheumatic Diseases; C. Gram Gjesdal, MD, PhD, Department of Clinical Science, University of Bergen, and BEaBIRD, Department of Rheumatology, Haukeland University Hospital. Address correspondence to Dr. L.K. Brekke, HSR AS, PB 2175, 5504 Haugesund, Norway. E-mail: lene.kristin.brekke@hsr.as. Accepted for publication June 25, 2019.
Andreas P. Diamantopoulos
From the Hospital for Rheumatic Diseases, Haugesund; Department of Clinical Science, University of Bergen, Bergen; Bergen Group of Epidemiology and Biomarkers in Rheumatic Disease (BEaBIRD), Department of Rheumatology, and Centre for Clinical Research, Haukeland University Hospital, Bergen; Martina Hansens Hospital, Bærum, Norway. This work was supported by unrestricted research grants from the Norwegian Association of Heart and Lung Patients; The Norwegian Rheumatism Association; Marit Hansens Memorial Fund; Merck Sharp & Dohme; Odd Fellow Medical Research Fund; and The Raagholt Foundation. L.K. Brekke, MD, Hospital for Rheumatic Diseases, and Department of Clinical Science, University of Bergen; B.T. Fevang, MD, PhD, Department of Clinical Science, University of Bergen, and BEaBIRD, Department of Rheumatology, Haukeland University Hospital; A.P. Diamantopoulos, MD, PhD, MPH, Martina Hansens Hospital; J. Assmus, PhD, Centre for Clinical Research, Haukeland University Hospital; E. Esperø, MD, Hospital for Rheumatic Diseases; C. Gram Gjesdal, MD, PhD, Department of Clinical Science, University of Bergen, and BEaBIRD, Department of Rheumatology, Haukeland University Hospital. Address correspondence to Dr. L.K. Brekke, HSR AS, PB 2175, 5504 Haugesund, Norway. E-mail: lene.kristin.brekke@hsr.as. Accepted for publication June 25, 2019.
Jörg Assmus
From the Hospital for Rheumatic Diseases, Haugesund; Department of Clinical Science, University of Bergen, Bergen; Bergen Group of Epidemiology and Biomarkers in Rheumatic Disease (BEaBIRD), Department of Rheumatology, and Centre for Clinical Research, Haukeland University Hospital, Bergen; Martina Hansens Hospital, Bærum, Norway. This work was supported by unrestricted research grants from the Norwegian Association of Heart and Lung Patients; The Norwegian Rheumatism Association; Marit Hansens Memorial Fund; Merck Sharp & Dohme; Odd Fellow Medical Research Fund; and The Raagholt Foundation. L.K. Brekke, MD, Hospital for Rheumatic Diseases, and Department of Clinical Science, University of Bergen; B.T. Fevang, MD, PhD, Department of Clinical Science, University of Bergen, and BEaBIRD, Department of Rheumatology, Haukeland University Hospital; A.P. Diamantopoulos, MD, PhD, MPH, Martina Hansens Hospital; J. Assmus, PhD, Centre for Clinical Research, Haukeland University Hospital; E. Esperø, MD, Hospital for Rheumatic Diseases; C. Gram Gjesdal, MD, PhD, Department of Clinical Science, University of Bergen, and BEaBIRD, Department of Rheumatology, Haukeland University Hospital. Address correspondence to Dr. L.K. Brekke, HSR AS, PB 2175, 5504 Haugesund, Norway. E-mail: lene.kristin.brekke@hsr.as. Accepted for publication June 25, 2019.
Elisabet Esperø
From the Hospital for Rheumatic Diseases, Haugesund; Department of Clinical Science, University of Bergen, Bergen; Bergen Group of Epidemiology and Biomarkers in Rheumatic Disease (BEaBIRD), Department of Rheumatology, and Centre for Clinical Research, Haukeland University Hospital, Bergen; Martina Hansens Hospital, Bærum, Norway. This work was supported by unrestricted research grants from the Norwegian Association of Heart and Lung Patients; The Norwegian Rheumatism Association; Marit Hansens Memorial Fund; Merck Sharp & Dohme; Odd Fellow Medical Research Fund; and The Raagholt Foundation. L.K. Brekke, MD, Hospital for Rheumatic Diseases, and Department of Clinical Science, University of Bergen; B.T. Fevang, MD, PhD, Department of Clinical Science, University of Bergen, and BEaBIRD, Department of Rheumatology, Haukeland University Hospital; A.P. Diamantopoulos, MD, PhD, MPH, Martina Hansens Hospital; J. Assmus, PhD, Centre for Clinical Research, Haukeland University Hospital; E. Esperø, MD, Hospital for Rheumatic Diseases; C. Gram Gjesdal, MD, PhD, Department of Clinical Science, University of Bergen, and BEaBIRD, Department of Rheumatology, Haukeland University Hospital. Address correspondence to Dr. L.K. Brekke, HSR AS, PB 2175, 5504 Haugesund, Norway. E-mail: lene.kristin.brekke@hsr.as. Accepted for publication June 25, 2019.
Clara Gram Gjesdal
From the Hospital for Rheumatic Diseases, Haugesund; Department of Clinical Science, University of Bergen, Bergen; Bergen Group of Epidemiology and Biomarkers in Rheumatic Disease (BEaBIRD), Department of Rheumatology, and Centre for Clinical Research, Haukeland University Hospital, Bergen; Martina Hansens Hospital, Bærum, Norway. This work was supported by unrestricted research grants from the Norwegian Association of Heart and Lung Patients; The Norwegian Rheumatism Association; Marit Hansens Memorial Fund; Merck Sharp & Dohme; Odd Fellow Medical Research Fund; and The Raagholt Foundation. L.K. Brekke, MD, Hospital for Rheumatic Diseases, and Department of Clinical Science, University of Bergen; B.T. Fevang, MD, PhD, Department of Clinical Science, University of Bergen, and BEaBIRD, Department of Rheumatology, Haukeland University Hospital; A.P. Diamantopoulos, MD, PhD, MPH, Martina Hansens Hospital; J. Assmus, PhD, Centre for Clinical Research, Haukeland University Hospital; E. Esperø, MD, Hospital for Rheumatic Diseases; C. Gram Gjesdal, MD, PhD, Department of Clinical Science, University of Bergen, and BEaBIRD, Department of Rheumatology, Haukeland University Hospital. Address correspondence to Dr. L.K. Brekke, HSR AS, PB 2175, 5504 Haugesund, Norway. E-mail: lene.kristin.brekke@hsr.as. Accepted for publication June 25, 2019.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 3
1 Mar 2024
Risk of Cancer in 767 Patients with Giant Cell Arteritis in Western Norway: A Retrospective Cohort with Matched Controls
Lene Kristin Brekke, Bjørg-Tilde Svanes Fevang, Andreas P. Diamantopoulos, Jörg Assmus, Elisabet Esperø, Clara Gram Gjesdal
The Journal of Rheumatology Jul 2019, jrheum.190147; DOI: 10.3899/jrheum.190147
Risk of Cancer in 767 Patients with Giant Cell Arteritis in Western Norway: A Retrospective Cohort with Matched Controls
Lene Kristin Brekke, Bjørg-Tilde Svanes Fevang, Andreas P. Diamantopoulos, Jörg Assmus, Elisabet Esperø, Clara Gram Gjesdal
The Journal of Rheumatology Jul 2019, jrheum.190147; DOI: 10.3899/jrheum.190147